Domo signs strategic collaboration agreement with AWS for AI solutions
CLEVELAND - Avient Corporation (NYSE:AVNT), a materials solutions provider with a $3.2 billion market cap, announced Thursday that its Board of Directors has declared a quarterly cash dividend of $0.27 per share on the company’s common stock. The dividend represents a 3.12% yield, continuing the company’s impressive 14-year streak of consecutive dividend increases.
The dividend will be paid on October 8, 2025, to stockholders of record as of September 12, 2025, according to a press release issued by the company. InvestingPro analysis reveals the company maintains strong financial health with liquid assets exceeding short-term obligations and a healthy current ratio of 2.05.
Avient, which employs more than 9,000 people globally, specializes in a range of materials solutions including colorants, advanced composites, functional additives, engineered materials, and Dyneema fiber products.
The quarterly dividend announcement represents a routine financial update for the company’s shareholders.
In other recent news, Avient Corporation reported its financial results for the first quarter of 2025, meeting Wall Street expectations with an adjusted earnings per share (EPS) of $0.76, while revenue slightly missed forecasts, coming in at $827 million against the expected $830.8 million. The company observed a 2% growth in organic sales, with notable increases in Latin America and Asia, although sales in the US and Canada declined by 3%. Avient also announced a quarterly dividend of $0.27 per share, emphasizing its commitment to shareholder value. In governance updates, Ashish K. Khandpur was promoted to Chairman of the Board, while Christopher L. Pederson, Senior Vice President and President of Specialty Engineered Materials, announced his retirement effective June 2025. Shareholders recently approved executive compensation and ratified Ernst & Young LLP as the independent auditor for the fiscal year. Additionally, Avient is focusing on innovation and sustainability, with new product launches in healthcare and defense sectors. These developments reflect Avient’s strategic direction and operational adjustments amidst market dynamics.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.